FDA Gives Approval to Zurzuvae Pill to Ease Postpartum Depression
MONDAY, Aug. 7, 2023 -- The U.S. Food and Drug Administration on Friday approved a new pill, called Zurzuvae (zuranolone), that may quickly ease severe postpartum depression and help millions of women regain their emotional equilibrium following... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 7, 2023 Category: General Medicine Source Type: news
Sage market cap cut in half as markets open after partial drug approval
The Cambridge drugmaker saw its market value drop by about $1 billion in the first minutes of trading Monday, following a partial approval of a new depression drug late Friday. Cambridge-based Sage had applied to market the depression drug, zuranolone, as a treatment for both major depressive disorder (MDD) and postpartum depression (PPD). The U.S. Food and Drug Administration approved zuranolone, now marketed under the name Zurzuvae, for PPD but rejected it as a treatment for MDD, citing a lack of substantive data. The latter disorder would have presented a much larger market opportunity, analysts have noted. "We are deva...
Source: bizjournals.com Health Care:Biotechnology headlines - August 7, 2023 Category: Biotechnology Authors: Rowan Walrath Source Type: news
FDA approves first oral treatment for postpartum depression
The U.S. Food and Drug Administration approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD) in adults. PPD is a major depressive episode that typically occurs after childbirth but can also begin during the later stages of pregnancy. Until now, treatment for PPD was only available as an IV injection given by a health care provider in certain health care facilities. (Source: World Pharma News)
Source: World Pharma News - August 7, 2023 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news
What new parents need to know about groundbreaking postpartum treatment
Experts say FDA approval of a first-of-its-kind pill to treat postpartum depression is a big step but not a panacea. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - August 6, 2023 Category: Consumer Health News Authors: Emmanuel Felton Source Type: news
The FDA just approved a pill for postpartum depression. Here ’s what that means
Postpartum depression is one of the most common complications of childbirth, affecting about a half million Americans each year. It’s among the leading causes of pregnancy-related death. Now, the FDA has approved the first pill for treating postpartum depression. Patricia Kinser, co-chair of…#postpartum #fda #patriciakinser #johnyang (Source: Reuters: Health)
Source: Reuters: Health - August 5, 2023 Category: Consumer Health News Source Type: news
What To Know About Zuranolone —The First FDA-Approved Oral Pill For Postpartum Depression
About one in seven women experience postpartum depression after giving birth. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - August 5, 2023 Category: Pharmaceuticals Authors: Ty Roush, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news topline Source Type: news
---
CNN's Lynda Kinkade speaks with a medical expert about the potentially life-changing drug, Zuranolone, that can help new mothers who are suffering from postpartum depression. (Source: CNN.com - Health)
Source: CNN.com - Health - August 5, 2023 Category: Consumer Health News Source Type: news
FDA approves Zuranolone, the first pill EVER to treat postpartum depression -suffered by one in SEVEN new moms
The Food and Drug Administration has approved the first ever pill to treat postpartum depression (PPD) which is suffered by around one in seven new mothers. (Source: the Mail online | Health)
Source: the Mail online | Health - August 5, 2023 Category: Consumer Health News Source Type: news
FDA approves first postpartum depression pill in the US
Postpartum depression is a serious mental illness that can develop in about 1 in 7 new mothers after childbirth. (Source: PsycPORT.com)
Source: PsycPORT.com - August 5, 2023 Category: Psychiatry Source Type: news
FDA Approves Zurzuvae, First Pill For Postpartum Depression, What You Need To Know
Zurzuvae is the first ever oral medication for postpartum depression, a major depressive episode that affects an estimated one in seven mothers. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - August 5, 2023 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma standard Source Type: news
FDA Approves Zurzuvae, First Pill For Postpartum Depression: What You Need To Know
Zurzuvae is the first ever oral medication for postpartum depression, a major depressive episode that affects an estimated one in seven mothers. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - August 5, 2023 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma standard Source Type: news
FDA Gives Approval to Pill to Ease Postpartum Depression
SATURDAY, Aug. 5, 2023 -- The U.S. Food and Drug Administration on Friday approved a new pill, called zuranolone, that may quickly ease severe postpartum depression and help millions of women regain their emotional equilibrium following... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 5, 2023 Category: General Medicine Source Type: news
FDA Gives Approval to Zurzuvae to Ease Postpartum Depression
SATURDAY, Aug. 5, 2023 -- The U.S. Food and Drug Administration on Friday approved a new pill, called zuranolone, that may quickly ease severe postpartum depression and help millions of women regain their emotional equilibrium following... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 5, 2023 Category: General Medicine Source Type: news
US approves postpartum depression pill
Clinical trials showed the drug helped to reduce depressive symptoms in as little as three days. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - August 5, 2023 Category: Consumer Health News Source Type: news
FDA OKs First Pill for Postpartum Depression
(MedPage Today) -- The FDA approved zuranolone (Zurzuvae) as the first oral treatment for postpartum depression, the agency announced late on Friday.
Until now, brexanolone (Zulresso) has been the only other treatment with an indication for postpartum... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - August 5, 2023 Category: Psychiatry Source Type: news
